TetraLogic Pharmaceuticals Corporation
TLOG · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Market Cap | $3,901 | $7,584 | $4,397 | $42,871 |
| - Cash | $5,885 | $8,676 | $14,542 | $15,302 |
| + Debt | $30,809 | $29,925 | $29,082 | $28,279 |
| Enterprise Value | $28,825 | $28,834 | $18,937 | $55,847 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9,183 | -$5,008 | -$9,313 | -$12,582 |
| % Margin | – | – | – | – |
| Net Income | -$8,635 | -$8,464 | -$12,744 | -$15,914 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.35 | -0.34 | -0.51 | -0.64 |
| % Growth | -2.9% | 33.3% | 20.3% | – |
| Operating Cash Flow | -$2,794 | -$5,862 | -$6,032 | -$9,193 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$2,794 | -$5,862 | -$6,032 | -$9,193 |